Find clinical trials for Multiple Myeloma in San Diego, CA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Multiple Myeloma trials near San Diego, CA, USA:
this study is to determine the maximum-tolerated dose (MTD) and recommended Phase 2 dose (RP2D) of ION251 in patients with relapsed/refractory multiple...
Phase 1
La Jolla, California, United States and 5 other locations
This is a phase 1, multicenter, open-label study evaluating the safety and efficacy of ruxolitinib, steroids and lenalidomide among MM patients who c...
Phase 1
Encinitas, California, United States and 12 other locations
The purpose of this study is to determine the overall response rate of patients with Multiple Myeloma to the combination of Daratum...
Phase 2
La Jolla, California, United States of America
progression-free survival (PFS) in participants with newly diagnosed multiple myeloma (a blood cancer of plasma cells) who are not ...
Phase 3
San Diego, California, United States and 211 other locations
versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) followed by Autologous Stem Cell Transplant (ASCT) in newly diagnosed multiple...
Phase 3
San Diego, California, United States and 117 other locations
with BMS-986405 in participants with relapsed and refractory multiple myeloma (MM). The dose escalation part (Part A) of the study ...
Phase 1
La Jolla, California, United States and 19 other locations
The main aims of this study are to test for any side effects from modakafusp alfa in combination therapy and to determine the recommended dose of com...
Phase 1
San Diego, California, United States and 20 other locations
Phase 1 study comprised of open-label, dose escalation, multiple cohorts of P-BCMA-ALLO1 allogeneic T stem cell memory (Tscm) CAR-T cells in ...
Phase 1
San Diego, California, United States and 13 other locations
and dexamethasone (PVd) in participants with relapsed or refractory multiple myeloma (RRMM) who received between 1 to 3 prior lines...
Phase 3
San Diego, California, United States and 218 other locations
38 (CD38) treatment naive participants with newly diagnosed multiple myeloma who are MRD positive as determined by next generation...
Phase 3
La Jolla, California, United States and 72 other locations
Clinical trials
Research sites
Resources
Legal